Message from the Chief
Welcome to the Stanford Division of Hematology, a dynamic center for basic and translational research, clinical trials, patient care, and teaching. Our physicians, scientists, staff, and trainees collaborate to advance the understanding and treatment of hematologic disorders, all with the goal of improving outcomes for patients with these diseases. In pursuit of this objective, we engage with the broader Stanford community to bring innovation to our efforts.
The miracle of a patient's recovery
A 28-year-old woman has a miscarriage while on vacation in Mexico. When she goes to the doctor, a nightmare begins. She ends up spending the next five years in and out of hospitals. At one point, she’s told she’s going to die. She takes chemotherapy, sees a naturopath, sees doctors in her native Ukiah and at Stanford, even goes to Philadelphia and Boston to see experts on the disease. They all agree that nothing can be done.
Professor Emeritus Dr. Stanley Schrier Celebrates 50 Years with the Stanford Division of Hematology
The Schrier Fellow Scholar Award (SFSA) was created to honor the outstanding career and achievements of Dr. Stanley Schier. To find out more about making a gift to the SFSA, click below.
The World Within US
As a child, Ami Bhatt, MD, PhD (assistant professor, Hematology, and assistant professor, Genetics), found herself drawn to science.
Group of rare blood cancers respond to new treatment pioneered by Stanford physician
Patients with a group of cancers known as advanced systemic mastocytosis have few treatment options. A drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.